Keith Laemont, MS, LATG

Keith laemont, ms, latg

bookmark on deepenrich
location of Keith Laemont, MS, LATGRaleigh-Durham-Chapel Hill Area
Phone number of Keith Laemont, MS, LATG+91 xxxx xxxxx
Followers of Keith Laemont, MS, LATG401 followers
  • Timeline

    Sept 1989 - Sept 1994

    Senior Research Pharmacologist

    Scios Nova Inc
    May 1995 - Sept 2005

    Senior Scientist | Scientist

    Pfizer
    Sept 2005 - Sept 2013

    Research Scientist

    Charles River Laboratories
    Jul 2014 - Feb 2016

    Project Manager | Sr. Research Biologist

    Alion Science and Technology
    Aug 2016 - Dec 2016

    Associate Director

    SoBran BioScience
    May 2017 - Jun 2022

    Laboratory Research Analyst

    Duke University School of Medicine
    Current Company
    Aug 2022 - now

    Project Manager

    ChemoGenics BioPharma
  • About me

    Project Manager at ChemoGenics BioPharma

  • Education

    • Maryville college

      -
      Biology
    • Villanova university

      -
      M.s. biology

      Thesis title: The role of phosphatidylinositol turnover in mediating the actions of carbachol in the rat uterus

    • Texas christian university

      -
      B.s. biology
  • Experience

    • Scios nova inc

      Sept 1989 - Sept 1994
      Senior research pharmacologist

      •Implemented in vivo and in vitro models of inflammation to test leukocyte recruitment inhibitors (leumedins) for efficacy and Beta-2 integrin dependency.•Rodent evaluation of subtype-selective muscarinic antagonists for inhibition of choline derivative-induced effects as models of pulmonary disease.

    • Pfizer

      May 1995 - Sept 2005
      Senior scientist | scientist

      Had a preclinical role in developing Lyrica for fibromyalgia pain.....the most significant accomplishment of my entire research career!•Promoted to a Ph.D.-level researcher that developed, characterized, and improved in vivo rodent and rabbit models for evaluating novel alpha-2-delta ligands, NSRIs, antagonists of NMDA, MgluR5 and NK-1, and inhibitors of PDE-IV, MMP, MEK, and COX-2 for potential treatment of fibromyalgia, osteoarthritis, and/or rheumatoid arthritis. •Performed preclinical development studies to advance Lyrica to eventual NDA approval for fibromyalgia pain.•Directed activities of an Associate Scientist and temporary employees. •Appointed Department contact for animal room census projections/renovation. •Assigned to ensure team results were entered into company-wide data base. •Wrote vertebrate use forms, and served on the Institutional Animal Care and Use Committee. Show less

    • Charles river laboratories

      Sept 2005 - Sept 2013
      Research scientist

      •In vivo evaluation of novel antineoplastics from pharmaceutical/biotech clients in rodent xenograft models. •Ran client-based studies and formulated drugs for dosing, while maintaining a rapid pace with a high work load. •Led all technical aspects of the company's Inflammation TA, including validation of new models, problem solving instrumentation & assays, and interviewing/training/mentoring staff.

    • Alion science and technology

      Jul 2014 - Feb 2016
      Project manager | sr. research biologist

      • Led a team of 13 senior/associate technicians and facility staff (6 direct reports) to provide inhalation/oral toxicology research support services to the NIEHS, including their National Toxicology Program.• Laboratory operations management.• Managed client budget resources and technical development of staff.• Chaired Alion’s IACUC.• Improved information collection and necropsy processes, resulting in a better quality product delivered with documented Customer satisfaction.

    • Sobran bioscience

      Aug 2016 - Dec 2016
      Associate director

      • Directed GLP rodent toxicology contract research at the Browns Summit, NC and Baltimore, MD sites.• Successfully achieved GLP site readiness in NC within a 2-month time line.• Authored, reviewed, and maintained study protocols and associated amendments as per 21 CFR, part 58.• Ensured all deviations from protocols were documented, and reported to study director & client.• Assisted clients with formulation of their test articles.

    • Duke university school of medicine

      May 2017 - Jun 2022
      Laboratory research analyst

      As part of Duke's Clinical & Translational Science Institute within the School of Medicine, the Preclinical Translational Research Unit provided animal model support (primarily cancer) to the university and external organizations. The research unit, however, was eliminated 6/30/2022.• Served as Operations Manager for coordinating study planning and execution.• Point of contact for all IACUC-related activities.• Imaged blood flow and hemoglobin saturation in dorsal window-implanted mice.• Maintained bench skills and staff guidance. Show less

    • Chemogenics biopharma

      Aug 2022 - now
      Project manager

      Solely in charge of all in vivo studies, particularly pharmacokinetic experiments, in rodents off-site. Working to achieve PHS Assurance to bring studies on-site.

  • Licenses & Certifications

    • Research animal coordinator certification

      Duke university animal care & use program
      Aug 2019
    • Laboratory animal technologist

      Aalas
      Mar 2015
  • Honors & Awards

    • Awarded to Keith Laemont, MS, LATG
      Merck Key Contributor Award - March 1, 2013 Awarded from client for dedication to the Merck project at Charles River Laboratories.
    • Awarded to Keith Laemont, MS, LATG
      Charles River "Achieving Customer Excellence" Award - June 1, 2012 For solving problems with the collagen antibody-induced arthritis model, and retaining the client.
    • Awarded to Keith Laemont, MS, LATG
      Best Poster by a Non-Ph.D. Researcher Society for Neuroscience (MI Chapter) May 1, 2005 "Temporal summation in rats: a novel approach in methodology to assess central sensitization"
    • Awarded to Keith Laemont, MS, LATG
      Pfizer Colleague Recognition Award - August 1, 2002 Development of the rabbit osteoarthritis and rat fibromyalgia models.
    • Awarded to Keith Laemont, MS, LATG
      Pfizer Colleague Recognition Award - June 1, 2001 Coordination and execution of a MEK pre-candidate alert notice toxicology study.
    • Awarded to Keith Laemont, MS, LATG
      Parke-Davis Colleague Recognition Award - 2000 Participation in Y2K preparation.
    • Awarded to Keith Laemont, MS, LATG
      Scios Nova Presidential Award - September 1, 1993 Teamwork on the Leumedin project.
    • Awarded to Keith Laemont, MS, LATG
      Full Scholarship and Teaching Assistantship Villanova University August 1, 1987
  • Volunteer Experience

    • Jobs Network Steering Committee

      Issued by North Carolina Biotechnology Center on Feb 2014
      North Carolina Biotechnology CenterAssociated with Keith Laemont, MS, LATG